Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in ABBV — AbbVie Inc.

CIK 1179392 NEW YORK, NY
Back to ABBV Full portfolio

Position in ABBV

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$38,804,130
+$12,593,586 QoQ
Shares Held
178,418
+55.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Mar 31, 2026
CallValue
$3,914,820
CallShares
18,000
PutValue
$5,002,270
PutShares
23,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

TWO SIGMA INVESTMENTS, LP holds $1,148,943,923 across 14 Drug Manufacturers - General names. ABBV ranks #5 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BMY
Bristol Myers Squibb Co
 11,535,106 $699,604,178
2 NVO
Novo Nordisk A S
 6,286,501 $231,028,911
3 LLY
ELI LILLY & Co
 64,550 $59,371,153
4 AZN
Astrazeneca PLC
 203,026 $40,040,787
5 ABBV
AbbVie Inc.
This page 		178,418 $38,804,130
6 AMGN
Amgen Inc
 71,680 $25,220,608
7 OGN
Organon & Co.
 3,137,020 $18,790,749
8 JNJ
Johnson & Johnson
 53,253 $13,017,163

All Filings in ABBV

Export CSV
45 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $38,804,130 178,418
2026-03-31 $3,914,820 18,000
2026-03-31 $5,002,270 23,000
2025-12-31 $26,210,544 114,712
2025-12-31 $5,095,327 22,300
2025-12-31 $7,037,492 30,800
2025-09-30 $2,570,094 11,100
2025-09-30 $37,781,771 163,176
2025-09-30 $2,546,940 11,000
2025-06-30 $47,495,703 255,876
2025-03-31 $2,538,963 12,118
2024-12-31 $1,012,890 5,700
2024-09-30 $1,461,352 7,400
2024-06-30 $2,928,189 17,072
2024-03-31 $123,400,793 677,654
2023-12-31 $130,435,304 841,681
2023-09-30 $134,778,710 904,191
2023-06-30 $247,483,246 1,836,883
2023-03-31 $100,935,395 633,340
2022-12-31 $27,864,796 172,420
2022-03-31 $145,953,631 900,337
2021-12-31 $7,284,520 53,800
2021-12-31 $5,944,060 43,900
2021-12-31 $260,813,708 1,926,246
2021-09-30 $93,697,500 868,615
2021-09-30 $7,647,983 70,900
2021-09-30 $7,194,929 66,700
2021-06-30 $237,819,197 2,111,321
2021-06-30 $15,105,024 134,100
2021-06-30 $22,539,264 200,100
2021-03-31 $259,749,319 2,400,197
2021-03-31 $13,332,704 123,200
2021-03-31 $7,283,206 67,300
2020-12-31 $253,263,811 2,363,638
2020-12-31 $13,243,740 123,600
2020-12-31 $9,279,190 86,600
2020-09-30 $11,710,783 133,700
2020-09-30 $250,415,868 2,858,955
2020-09-30 $15,915,103 181,700
2020-06-30 $175,669,055 1,789,255
2020-06-30 $6,911,872 70,400
2020-06-30 $3,357,756 34,200
2020-03-31 $5,226,634 68,600
2020-03-31 $5,980,915 78,500
2020-03-31 $94,300,515 1,237,702

Report a Problem

Category
Description
Email (optional, for follow-up)